A drug trial to evaluate the safety and efficacy of daratumumab, an agent already approved for other diseases, in combination with standard background anti-rheumatic therapy in patients with moderate-to-severe systemic lupus erythematosus A drug trial to evaluate the safety and efficacy of daratumumab, an agent already approved for other ...
A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination with Standard Background Therapy in Participants with Moderate to Severe Systemic Lupus Erythematosus - DARALUP A Monocenter, Open Label Study to Evaluate the Safety and Efficacy of Daratumumab in Combination wit ...